[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
March 25, 1939

CONFERENCES ON THERAPYTHE CHOICE OF DRUGS

JAMA. 1939;112(12):1151-1156. doi:10.1001/jama.1939.62800120004010

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Dr.HarryGold: It is a major accomplishment in drug therapy to be able to select wisely from a host of preparations of the same fundamental drug, each differing from the other in minor properties and in major claims. At least three factors constitute the basis for selection: (1) sound pharmacologic evidence, (2) clinical experience which meets high standards of scientific evidence and (3) cost. This morning we shall have time to consider choice in but few of the major groups of therapeutic agents. Dr. Eggleston will consider choice among the digitalis preparations and the purine bases.

DIGITALIS; PURINE BASES  Dr.CaryEggleston: Today well standardized, reasonably uniform and trustworthy preparations of digitalis are commercially available in considerable numbers. Experience and pharmacologic studies seem to indicate that our choice of digitalis bodies should largely be limited to one for oral administration and one for intravenous administration, with immeasurably less emphasis

First Page Preview View Large
First page PDF preview
First page PDF preview
×